Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

Cited by (318)

Items 201–300 of 318

  1. Inhibiting system xC− and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers
    Nicholas James Clemons, David S. Liu, Cuong P. Duong, Wayne Allen Phillips · 2017 · Molecular & Cellular Oncology
  2. Retinal Neurodegeneration in Euglycemic Hyperinsulinemia, Prediabetes, and Diabetes
    Moein Ebrahimi, Sobha Sivaprasad, Paul M. Thompson, George L. Perry · 2022 · Ophthalmic Research
  3. Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
    Carlos Lopez-Blazquez, Carlos Lacalle-González, Lara Sanz-Criado, Michael Ochieng’ Otieno, Jesús García‐Foncillas, Javier Martínez‐Useros · 2023 · International Journal of Molecular Sciences
  4. How I Treat TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Michael L. Loschi, Pierre Fenaux, Thomas Cluzeau · 2022 · Cancers
  5. APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
    Xuqin Xie, Chuanwen Fan, Bin Luo, Jing Zhang, Lasse D. Jensen, Jonas Burman, Carolin Jönsson, Anna Ljusberg, Peter Larsson, Zengren Zhao et al. · 2023 · Molecular Cancer Therapeutics
  6. Covalent Fragments Acting as Tyrosine Mimics for Mutant p53-Y220C Rescue by Nucleophilic Aromatic Substitution
    Theresa Klett, Jason Stahlecker, Simon Jaag, Benedikt Masberg, Cornelius Knappe, Michael Lämmerhofer, M.P. Coles, Thilo Stehle, Frank M. Boeckler · 2024 · ACS Pharmacology & Translational Science
  7. Research progress of ferroptosis in glaucoma and optic nerve damage
    Sijia Huang, Kexin Liu, Ying Su, Feng Wang, Tao Feng · 2022 · Molecular and Cellular Biochemistry
  8. Mechanism and application prospect of ferroptosis inhibitors in improving osteoporosis
    Jing Wang, Tingrui Chen, Fei Gao · 2024 · Frontiers in Endocrinology
  9. Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression
    Elena Gennadyevna Varlamova · 2025 · Archives of Biochemistry and Biophysics
  10. Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma
    Michael Müller, Lisa Rösch, Sara Najafi, Charlotte Gatzweiler, Johannes Ridinger, Xenia F. Gerloff, David Jones, Jochen Baßler, Sina Kreth, Sabine A. Stainczyk et al. · 2021 · Cancers
  11. Transcriptional Regulation of Amino Acid Transport in Glioblastoma Multiforme
    Robyn A. Umans, Joelle Martin, Megan E. Harrigan, Dipan C. Patel, Lata Chaunsali, Aarash K. Roshandel, Kavya V. Iyer, Michael Duane Powell, Kenneth J. Oestreich, Harald W. Sontheimer · 2021 · Cancers
  12. PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis
    Giulia Elda Valenti, Antonella Roveri, Rina Venerando, Paola Menichini, Paola Monti, Bruno Tasso, Nicola Traverso, Cinzia Domenicotti, Barbara Marengo · 2023 · Antioxidants
  13. 4-Octyl Itaconate Attenuates Postmenopausal Osteoporosis by Inhibiting Ferroptosis and Enhancing Osteogenesis via the Nrf2 Pathway
    You Li, Pengfei Li, Pengfei Li, Lei Yang, Haijun Li · 2025 · Inflammation
  14. A mechanism linking ferroptosis and ferritinophagy in melatonin-related improvement of diabetic brain injury
    Jiaojiao Yu, Yu Zhang, Qin Zhu, Zhengrui Ren, Mengting Wang, Sasa Kong, Hongbo Lv, Tao Xu, Zhaoyu Xie, Jun Han et al. · 2024 · iScience
  15. Inhibition of ASIC1a reduces ferroptosis in rheumatoid arthritis articular chondrocytes via the p53/ NRF2 / SLC7A11 pathway
    Jie Tang, Wenqiang Liu, Zihan Li, Can Shen, Longbiao Zhang, Cheng Wang, Fengshuo Wang, Zhuoyan Zai, Xuewen Qian, Weirong Hu et al. · 2025 · The FASEB Journal
  16. Feasibility of [18F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer
    Seong-Woo Bae, Jianbo Wang, Dimitra K. Georgiou, Xiaoxia Wen, Allison S. Cohen, Ling Geng, Mohammed Noor Tantawy, H. Charles Manning · 2023 · Tomography
  17. Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline
    Daniel J. Elson, Bach D. Nguyen, Sebastián Bernales, Sarvajit Chakravarty, Hyo Sang Jang, Nicholas A. Korjeff, Yi Zhang, Sierra F. Wilferd, David J. Castro, Christopher L. Plaisier et al. · 2023 · ACS Pharmacology & Translational Science
  18. Mechanism of non-thermal atmospheric plasma in anti-tumor: influencing intracellular RONS and regulating signaling pathways
    Wenjie Wang, Peijia Zheng, Liang Yan, Xiaoman Chen, Zhicheng Wang, Qi Liu · 2024 · Free Radical Research
  19. Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments
    HE Shu-fen, Wei-chao Han, Ying-ying Shao, Han-bin Zhang, Wen-xin Hong, Qiu-hong Yang, Yu-qing Zhang, Rui-rong He, Jing Sun · 2023 · Bioorganic Chemistry
  20. Ras functional proximity proteomics establishes mTORC2 as new direct ras effector
    Joanna R. Kovalski, Ronald L. Shanderson, Paul A. Khavari · 2019 · Oncotarget
  21. Traumatic brain injury-related ferroptosis: current perspectives
    Rongkun Zhu, Jizhou Pan, Yucong Min, Hao Wang, Jiankang Zhang, Fashun Liu · 2025 · Journal of molecular medicine
  22. SNF2L maintains glutathione homeostasis by initiating SLC7A11 transcription through chromatin remodeling
    Jiaguan Zhang, Zeshou Gao, Yi Yang, Zhenhao Li, Bo Wu, Chunxin Fan, Yuyan Zheng, Ruohan Yang, Fangrong Zhang, Xiaohuang Lin et al. · 2024 · Cell Death and Disease
  23. Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications
    Defeng Zhao, Wenze Li, Zhongyu Han, Ziyi Wang, Danni Li, Wenya Li · 2025 · Cell Death Discovery
  24. Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
    Rory Michael Shallis, Jan Philipp Bewersdorf, Maximilian F. Stahl, Stephanie Halene, Amer Methqal Zeidan · 2022 · Cancers
  25. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers
    Nelly M. Dabbour, Ahmed M. Salama, Thoria Donia, Radwa T. Al-Deeb, Abdullah M. Abd Elghane, Karima H. Badry, Samah A. Loutfy · 2021 · Journal of Drug Delivery Science and Technology
  26. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
    Nicole Santoro, Prassede Salutari, Mauro Di Ianni, Andrea Marra · 2024 · International Journal of Molecular Sciences
  27. Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
    Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, Nicholas James Clemons, Kenji Mark Fujihara, Thomas Riseborough, Amina F.A.S. Teunisse, Aart G. Jochemsen, Lars Abrahmsén, Giovanni Blandino et al. · 2022 · Cancers
  28. Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
    Huangqin Song, Xiaoxiao Wang, Chao Zhang, Jiefeng He · 2023 · Frontiers in Oncology
  29. A cautionary note on the use of N-acetylcysteine as a reactive oxygen species antagonist to assess copper mediated cell death
    Rebecca E. Graham, Richard J. R. Elliott, Alison F. Munro, Neil O. Carragher · 2023 · PLoS ONE
  30. Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer
    Subhasree Rajaram, Naoise C. Synnott, John Crown, Stephen F. Madden, Michael Joe Duffy · 2024 · Translational Oncology
  31. Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells
    Christophe Deben, Laurie Freire Boullosa, Andreas Domen, An Wouters, Bart Cuypers, Kris Laukens, Filip Lardon, Patrick Pauwels · 2021 · Cancer Drug Resistance
  32. Crosstalk between microwave ablation and ferroptosis: The next hot topic?
    Lu Yu, Min Cheng, Jie Liu, Xin Ye, Zhigang Wei, Jiamei Xu, Qi Xie, Jing Liang · 2023 · Frontiers in Oncology
  33. Combating malignant astrocytes: Strategies mitigating tumor invasion
    Robyn A. Umans, Harald W. Sontheimer · 2017 · Neuroscience Research
  34. Unraveling the Molecular Regulation of Ferroptosis in Respiratory Diseases
    Lujian Zhu, Jing Zhou, Chen Yu, Lei Gu, Qin Wang, Hanglu Xu, Yin Zhu, Maodong Guo, Minli Hu, Wei Peng et al. · 2024 · Journal of Inflammation Research
  35. Nrf2 in human cancers: biological significance and therapeutic potential
    Yu Tian · 2024 · American Journal of Cancer Research
  36. Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma
    Yuxiang Chi, Guoyuan Ma, Qiang Liu, Yunzhi Xiang, Defeng Liu, Jiajun Du · 2025 · Frontiers in Immunology
  37. Cathepsin S regulates ferroptosis sensitivity in hepatocellular carcinoma through the KEAP1-NRF2 signaling pathway
    Ru-Chen Xu, Jialei Sun, Fu Wang, Hua‐Hua Liu, Zhuoran Qi, Xuan Shi, Xiang‐Nan Yu, Taotao Liu, Shu‐Qiang Weng, Ling Dong et al. · 2025 · Redox Biology
  38. Curcumin Can Inhibit Zearalenone-Induced Ferroptosis in Porcine Intestinal Epithelial Cells via the p53/SLC7A11/GPX4 Pathway
    Dongwei Xiong, Weidong Qi, Miao Long · 2025 · Toxics
  39. Ferroptosis in tumor associated immune cells: A double-edged sword against tumors
    Jiachun Hu, Lei Cui, Benxin Hou, Xinyi Ding, Haisheng Liu, Weihong Sun, Yanjun Mi, Yibing Chen, Zhengzhi Zou · 2025 · Critical Reviews in Oncology/Hematology
  40. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
    Qikuan He, Pengyi Guo, Zhiyuan Bo, Haitao Yu, Jinhuan Yang, Yi Wang, Gang Chen · 2022 · Cancer Cell International
  41. Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis
    Wei-Chia Hung, Der‐Yen Lee, En‐Pei Isabel Chiang, Jia‐Ning Syu, Che‐Yi Chao, Mei‐Due Yang, Shu-Yao Tsai, Feng‐Yao Tang · 2020 · PLoS ONE
  42. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
    Yandong Miao, Zhi-Yong Kou, Jiangtao Wang, Denghai Mi · 2021 · World Journal of Clinical Cases
  43. Comprehensive analysis of disulfidptosis-related lncRNA features for prognosis and immune landscape prediction in colorectal cancer
    Chengyuan Dong, Yadong Guo, Ping Wang, Shiqi Yin, Xin Ge · 2023 · Frontiers in Oncology
  44. Deep learning untangles the resistance mechanism of p53 reactivator in lung cancer cells
    Soo Min Lee, Young-Hyun Han, Kwang‐Hyun Cho · 2023 · iScience
  45. Tmem39b promotes tumor progression and sorafenib resistance by inhibiting ferroptosis in hepatocellular carcinoma
    MING ZHUANG, Xue Zhang, Lu Li, Liming Wen, Jiamin Qin · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  46. GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A
    Hui‐min Zhang, Hanning Li, Enbo Qi, Yang Yang, Huiping Ma, Jie Ma, Xiwen Xiong, Jun Wang, Zhi‐fang Yang, Xing‐Hua Liao · 2025 · Cancer Science
  47. p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics
    Chen-Yun Wang, Chi-Hong Chao · 2022 · Frontiers in Oncology
  48. Mutant p53K120R expression enables a partial capacity to modulate metabolism
    Paola Monti, Silvia Ravera, Andrea Speciale, Irena Velkova, Giorgia Foggetti, Paolo Degan, Gilberto Fronza, Paola Menichini · 2022 · Frontiers in Genetics
  49. Novel investigational approaches for high-risk genetic subsets of AML: TP53, KMT2A, FLT3
    Kieran D. Sahasrabudhe, Alice S. Mims · 2022 · Hematology
  50. Emerging Roles of Ferroptosis in Skin Pathophysiology
    Alex S. Reznik, Kavita Vats, Kunal Singh, Alicia Mizes, Erik L. Jaklitsch, Hülya Bayır, Valerian E. Kagan, Yuri L. Bunimovich · 2025 · Journal of Investigative Dermatology
  51. Ferroptosis: A new horizon in cancer therapy
    Dan Shang, Linlin Zheng, Jie Chen, Tian Tan, Maojin Yao, Haibin Wu, Hong Wu, Chenhui Cao, Chuan Shan Xu · 2025 · Chinese Medical Journal
  52. Echinacoside as a Novel Ferroptosis Inducer in Hepatocellular Carcinoma: Mechanistic Insights from TP53/SLC7A11/GPX4 Pathway Modulation
    Pei Wang, Jianhao Lin, Deqi Su · 2025 · International Journal of Molecular Sciences
  53. Iron-catalyzed active lipid peroxides drive ultrafast collective cell death in blooming algae
    Yinjie Zhu, X.W. Wang, Yifan Tong, Chengzhen Jia, Huansheng Cao, Hong‐Ying Hu, Tao Yi · 2026 · Science
  54. Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis
    Kranthi Kumar Chougoni, Victoria L. Neely, Boxiao Ding, Eziafa Oduah, Vianna T. Lam, Bin Hu, Jennifer E. Koblinski, Bradford E. Windle, Swati Palit Deb, Sumitra Deb et al. · 2024 · Cancer Research Communications
  55. Ferroptosis and its relationship with cancer
    Chuanchao Su, Yiwen Xue, Siyu Fan, Xin Sun, Qian Si, Zhen Gu, Jingfei Wang, Runzhi Deng · 2025 · Frontiers in Cell and Developmental Biology
  56. Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
    Julia V. Milne, Bonnie Z. Zhang, Kenji Mark Fujihara, Swati Dawar, Wayne Allen Phillips, Nicholas James Clemons · 2021 · Scientific Reports
  57. Cysteine Metabolism in Cancer Progression and Therapy Resistance
    Dawn Sijin Nin, Shabana Binte Idres, Lih‐Wen Deng · 2021 · Springer eBooks
  58. Synergistic Effect of Erastin Combined with Nutlin-3 on Vestibular Schwannoma Cells as p53 Modulates Erastin-Induced Ferroptosis Response
    Weiwei He, Wenying Shu, Lu Xue, Yaoxuan Wang, Yongchuan Chai, Hao Wu, Zhaoyan Wang · 2022 · Journal of Oncology
  59. Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
    Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti, Federica Cavallo · 2022 · Biomedicines
  60. The p53 Tumor Suppressor and Copper Metabolism: An Unrevealed but Important Link
    Sergey A. Tsymbal, Alexander G. Refeld, О. А. Kuchur · 2022 · Molecular Biology
  61. APR-246 increases tumor antigenicity independent of p53
    Judith Michels, Divya Venkatesh, Cailian Liu, Sadna Budhu, Hong Zhong, Mariam Mathew George, Daniel Thach, Zhong‐Ke Yao, Ouathek Ouerfelli, Hengrui Liu et al. · 2023 · Life Science Alliance
  62. The STAT3/S100A6/P53/SLC7A11 axis mediates intervertebral disc degeneration by regulating ferroptosis in nucleus pulposus cells and the metabolism of the extracellular matrix
    Fengguang Yang, Xuening Liu, Yizhi Zhang, Xiaoming Qiu, Shuanhu Lei, Cangyu Zhang, Haijun Zhang, Yanni Duan, Xuchang Hu, Xuewen Kang · 2025 · The Spine Journal
  63. Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges
    ‎Anmar Ghanim Taki, Abdulkareem Shareef, Vimal Arora, Rami Joseph Oweis, S. Renuka Jyothi, Udaybir Singh, Samir Sahoo, Ashish Singh Chauhan, Farzona Alimova, Hayder Naji Sameer et al. · 2026 · Clinica Chimica Acta
  64. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity
    Shawn Lu Wen Tan, Hui Min Tan, Erez Israeli, Indah Fatihah, Vignesh Ramachandran, Shamsia Bte Ali, Shane Jun An Goh, Jillian Wee, Alicia Qian Ler Tan, Wai Leong Tam et al. · 2023 · Biochemical Journal
  65. The Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer
    Carolina Punziano, Silvia Trombetti, Michela Grosso, Maria Lina Tornesello, Raffaella Faraonio · 2025 · International Journal of Molecular Sciences
  66. Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells
    William M. Tahaney, Amanda L. Lanier, Jing Qian, Cassandra L. Moyer, Nghi D. Nguyen, Yanxia Ma, Jamal L. Hill, Reid Trenton Powell, CLIFFORD C. STEPHAN, PETER J. A. DAVIES et al. · 2026 · Breast Cancer Research and Treatment
  67. Risk stratification of acute myeloid leukemia: Assessment using a novel prediction model based on ferroptosis-immune related genes
    Xing Guo, Xiaogang Zhou · 2022 · Mathematical Biosciences & Engineering
  68. Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products
    Hari Sankaran, Simarjeet Negi, Lisa M. McShane, Yingdong Zhao, Julia Krushkal · 2022 · BMC Cancer
  69. PK11007 Covalently Inhibits Thioredoxin Reductase 1 to Induce Oxidative Stress and Autophagy Impairment in NSCLC Cells
    Hanziyi Zhou, Shibo Sun, Haowen Liu, Tong Li, Yiran Xu, Rui Ryan Yang, Haiyan Liu, Leiyu He, Weiping Xu, Shui Guan et al. · 2025 · Antioxidants
  70. Cytoglobin augments ferroptosis through autophagic degradation of ferritin in colorectal cancer cells
    Chengjiang Fan, Ziyang Luo, Qingfang Zheng, Yuhang Xu, Yao Qun Xu, Jianing Chen, You Meng, Haizhong Jiang, Kaitai Liu, Xi Yang · 2024 · Molecular and Cellular Biochemistry
  71. Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility
    Pooja Anil Shah, Klas G. Wiman, Karen M. Cichowski, Jordi Ahnert Rodon · 2025 · American Society of Clinical Oncology Educational Book
  72. Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia
    Martina Pasino, Andrea Speciale, Silvia Ravera, Giovanna Cutrona, Rosanna Massara, Nadia Bertola, Maurizio Viale, Irena Velkova, Andrea Nicola Mazzarello, Franco Fais et al. · 2025 · International Journal of Molecular Sciences
  73. tRNA-derived small RNAs: emerging regulators of ferroptosis in human diseases
    Jiqing Zhang, Mu Liu, Zhongjun Li · 2025 · Human Cell
  74. Exercise mitigates Alzheimer’s disease by targeting ferroptosis driven by cellular senescence
    Yuehan Yu, Kang Chen · 2026 · Frontiers in Cell and Developmental Biology
  75. TP53 signal pathway confers potential therapy target in acute myeloid leukemia
    Gelan Zhu, Jiayi Cai, Hua Zhong · 2023 · European Journal Of Haematology
  76. Pyrimidine Triones as Potential Activators of p53 Mutants
    Maryam M.J. Fallatah, Özlem Demir, Fiona V. Law, Linda Lauinger, Roberta Baronio, Linda Hall, Elodie Bournique, Ambuj Srivastava, Landon Tyler Metzen, Zane Norman et al. · 2024 · Biomolecules
  77. The association between ferroptosis and autophagy in cardiovascular diseases
    Yifan Zhang, Junjun Yang, Chenxi Ouyang, Ning Meng · 2024 · Cell Biochemistry and Function
  78. Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer
    Gui-Min Wen, Zhen-Ying Zhao, Xiaohui Zheng, Da-Hua Liu, Xia Pu · 2025 · Oncology Letters
  79. Ferroptose et cancer
    Rudy Birsen, Éric Grignano, Nicolas Chapuis, Didier Bouscary · 2021 · médecine/sciences
  80. Genome-wide CRISPR screens reveal APR-246 (Eprenetapopt) triggers ferroptosis and inhibits iron-sulfur cluster biogenesis
    Kenji Mark Fujihara, Bonnie Zhang, Thomas Daniel Jackson, Brunda Nijiagel, Ching‐Seng Ang, Iva Nikolić, Vivien R. Sutton, Joe Trapani, Kaylene J. Simpson, Diana Stojanovski et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias
    Kieran D. Sahasrabudhe, Mary Albrethsen, Alice S. Mims · 2023 · Expert Review of Hematology
  82. Unveiling the impact of glutathione (GSH) and p53 gene deletion on tumor cell metabolism by amino acid and proteomics analysis
    Hui Zhang, Jing Zhou, Lei Dong, Liyu Zhu, Yingjiang Ye · 2024 · Journal of Gastrointestinal Oncology
  83. Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
    Vid Mlakar, Ina Oehme, Laurence Lesne, Sara Najafi, Marc Ansari, Fabienne Gumy‐Pause · 2024 · Frontiers in Oncology
  84. Ferroptosis in Cancer Disease
    Behrouz Hassannia, Tom Vanden Berghe · 2019 · Springer eBooks
  85. P53, ROS: Redox Regulation Signaling, Metabolic Reprogramming, and Autophagy in Cancer
    Mohinder Pal Bansal · 2023 · Springer eBooks
  86. Oxidative and Antioxidant Systems in Ferroptosis of Cancer: Mechanisms, Regulations, and Therapeutic Targeting
    Deepak K, Pritam Roy, Maniklal Shee, Budhaditya Mukherjee, Aoife Ward, Mahitosh Mandal · 2026 · MedComm – Oncology
  87. Regulation and therapy: the role of ferroptosis in DLBCL
    Yifan Wang, Zhengmei He, Xinyu Dong, Yiming Yao, Qiuni Chen, Yuye Shi, Yuan Deng, Quane Zhang, Liang Yu, Hong Wang · 2025 · Frontiers in Pharmacology
  88. UBC9 silencing-mediated PPARα desumoylation induces inhibition of cell proliferation by ferroptosis in acute myeloid leukemia
    Xiaolu Song, Fangfang Shi, Xiaogang Wang, Peng Ye, Huafang Wang, Lai Jin, Jianping Lan · 2025 · Archives of Medical Science
  89. Global research status, hotspots and prospects of ferroptosis in glioma: a scientometric analysis
    Jing Liu, Zefeng He, Zhansen An, Shaodong Li, Liang Liu, Yingzi Liu · 2025 · Frontiers in Cellular Neuroscience
  90. The impact of p53 on the urea cycle and nitrogen metabolism enzymes: Mechanisms and implications for cancer development
    S. Iyer, Beata Schlichtholz · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  91. Endogenous antioxidants in the prognosis and treatment of lung cancer
    Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Deben · 2021 · Elsevier eBooks
  92. Understanding p53 structure and targeting mutant p53 for improved cancer therapy
    Qiang Zhang · 2018 · Figshare
  93. Probing Cancer Targets and Therapeutic Mechanisms using Small Molecules
    Yan Zhang · 2018
  94. Targeting Antioxidant Systems to Treat Pancreatic Cancer
    Francesco Gabriele Tatangelo Fazzari · 2018 · TSpace (University of Toronto)
  95. Tumor metabolic reprogramming in therapeutic resistance
    Peter M. Siegel, Josie Ursini‐Siegel · 2021 · Elsevier eBooks
  96. Defining Roles of Metabolic Reprogramming in Pancreatic Tumorigenesis and Tumor Maintenance
    Barbara Scott Nelson · 2020 · Deep Blue (University of Michigan)
  97. Metabolic reprogramming and redox perturbations
    Reem Aboushousha · 2021
  98. On the Reactivity of 2-Methylene-3-quinuclidinone in Water
    Lars Hagberg, Rune Ringom, Tim Blizzard, Corine Sandström, Per H. Svensson · 2023 · Heterocycles
  99. Data from Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function
    Shawn J. Macha, Balakrishna Koneru, Trevor A. Burrow, Charles Zhu, Dzmitry Savitski, Rakhshanda Layeequr Rahman, Catherine A. Ronaghan, Jonas Nance, Kristyn McCoy, Cody R. Eslinger et al. · 2023
  100. Supplemetary Material and Tables from Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth
    Helen B. Pearson, Jason Li, Valérie S. Méniel, Christina M. Fennell, Paul Waring, Karen G. Montgomery, Richard J. Rebello, Arthi A. Macpherson, Sarah Koushyar, Luc Furic et al. · 2023